Genes tied to drug-resistant cancers may shape therapy choices

Article

A gene abnormality may negatively impact efficacy of commonly used chemotherapy treatment used for breast cancer patients, report researchers at Dana-Farber Cancer Institute.

A gene abnormality in some women with breast cancer has been implicated in resistance to certain chemotherapy regimens, researchers at Dana-Farber Cancer Institute report.

Investigators studied DNA of samples of breast tumors from 85 patients prior to chemotherapy. In samples of drug-resistant tumors, 1 area on chromosome 8q22 had a number of extra or amplified copies of DNA stretches. In particular, when 2 genes in this area-LAPTM4B and YWHAZ-overexpressed protein, the tumor cells became resistant to the effects of anthracycline compounds (eg, doxorubicin, daunorubicin, epirubicin). About 1 in 5 samples of genes were linked to drug resistance. However, these cells remained susceptible to other classes of drugs, including cisplatin and paclitaxel.

Based on the study finding, researchers suggest they may be able to create a genetic test that will enable them to customize treatments to each patient’s tumor.

Li Y, Zou L, Li Q, et al. Nat Med. 2010; Jan. 24 (epub).

Recent Videos
Efficacy found from biopsychosocial approach to women’s sexual health | Image Credit: hermd.com.
Dr. Somi Javaid highlights disparities in sexual health | Image Credit: hermd.com.
How advancements in IVF are impacting embryologist workload and patient care | Image Credit: fertility.coopersurgical.com/our_experts
Study finds no causal link between maternal health in pregnancy and autism risk | Image Credit: med.nyu.edu/faculty.
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Related Content
© 2025 MJH Life Sciences

All rights reserved.